Conference abstract · 10 Sep 2012
Review articlePublished 2014
Bringing p53 into the Clinic
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The use of p53 as a biological marker to predict chemotherapeutic outcome has been challenging, with clinical research showing positive as well as negative correlations with p53 mutations. Recent research reveals the complexity that underlies the use of p53 as a single predictive marker as well as the challenges associated with classifying p53 mutations. It is becoming clear that various p53 mutations are associated with differential treatment response and outcomes. In addition, different drug regimens could also play a role in modifying the effects of p53 mutations on therapeutic outcome. Finally, we discuss improvements in the diagnostic detection of p53 mutations and gene signatures that may better reflect p53 functionality in tumors, which may serve as a more reliable tool in correlating p53 mutations to clinical response.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 10 Dec 2022
p53 mutations' prognostic significance in metastatic colorectal cancer: a comprehensive study and meta-analysis
Conference abstract · 27 Aug 2020
PROGNOSTIC IMPORTANCE OF MOLECULAR GENETIC MARKERS: Ki67, Bcl2, and p53 IN PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER
Conference abstract · 20 Jul 2017
Prognostic significance of miR-34a in respect of NF-κB, p53 expression in different stage/grade of female genital and gonadal cancer
Research article · 2013
Roles of Cell Cycle Regulators [p53, Cathepsin-D and Bax] in Prognostic Determination of Prostate Cancer and Benign Prostatic Hyperplasia
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ern Yu Tan”
- BylineArticles whose byline prints “Chit Fang Cheok”

